Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
iRGD-RBC Membrane Delivery Boosts Neuroblastoma PDT
2026-08-20
Wu and colleagues developed iRGD-functionalized red blood cell membrane vesicles to deliver the photosensitizer TPOR for neuroblastoma photodynamic therapy. The biomimetic carrier combined prolonged-circulation features with tumor-penetrating functionality, improving drug release, cellular uptake, apoptosis induction, migration inhibition, and tumor control compared with free TPOR.
-
IGFBP2–THBS1 Axis in GH-Mediated Bone Growth
2026-08-20
The reference study identifies an IGFBP2–THBS1 regulatory axis that links growth hormone treatment to IGF-1 signaling, chondrocyte proliferation, and hypertrophic differentiation in idiopathic short stature. Its combination of patient-derived proteomic analysis, human chondrocyte experiments, and IGFBP2 loss- and gain-of-function approaches provides a mechanistic framework for understanding variable responses to GH therapy.
-
PreScission Protease for Tag Cleavage
2026-08-19
PreScission Protease combines sequence-selective fusion protein tag cleavage with low-temperature handling, supporting recovery of native proteins for binding, structural, and chromatin-related assays. This article translates findings on Drosophila Keap1 and lamin Dm0 into practical purification and assay-design choices while distinguishing established evidence from workflow recommendations.
-
Structure-Based Screening of SARS-CoV-2 NSP15 Inhibitors
2026-08-19
The reference study used virtual screening and molecular dynamics simulations to evaluate natural products against the SARS-CoV-2 NSP15 endoribonuclease. Thymopentin and oleuropein produced the most favorable computational profiles, providing testable starting points for biochemical validation rather than clinically established antiviral treatments.
-
Dasatinib Monohydrate: BMS-354825 Research Guide
2026-08-18
Dasatinib Monohydrate, also called BMS-354825, is an ATP-competitive multitargeted tyrosine kinase inhibitor for BCR-ABL, SRC, KIT, and PDGFR research. Its nanomolar biochemical activity and activity against imatinib-resistant BCR-ABL variants support chronic myeloid leukemia research, while NET-related findings define important translational limits.
-
YTHDF2, m6A Decay, and Hippocampal Memory
2026-08-18
The reference study identifies YTHDF2-mediated degradation of m6A-modified mRNAs as an active constraint on hippocampus-dependent learning and memory. Forebrain YTHDF2 loss increased synaptic transmission and activity-dependent protein synthesis, while hippocampal rescue or manipulation of the downstream target SEMA4B reversed the memory phenotype.
-
Flubendazole in Metabolic-Autophagy Assays
2026-08-17
Flubendazole can support autophagy-focused experiments when pathway flux is interpreted alongside cellular metabolism. This guide connects the compound’s assay design to glutamine-dependent hepatic stellate-cell biology while clearly separating established evidence from practical recommendations.
-
Tacalcitol monohydrate: Research Workflows
2026-08-17
Tacalcitol monohydrate supports VDR-centered studies spanning keratinocyte differentiation, NGF biology, and colorectal cancer research. This practical guide translates its concentration ranges, formulation constraints, and 5-FU combination potential into reproducible workflows with troubleshooting and assay-design guidance.
-
Epalrestat: A Polyol Pathway Lens on Cancer
2026-08-15
Epalrestat is an aldose reductase inhibitor that offers a focused way to investigate polyol pathway inhibition, endogenous fructose production, and oxidative stress research. This article translates recent cancer-metabolism findings into practical assay decisions while distinguishing mechanistic hypotheses from validated evidence.
-
Finger Citron Mechanisms in NAFLD: Network and Cell Evidence
2026-08-14
This 2026 study integrates network pharmacology, molecular docking, compound characterization, and HepG2-cell validation to investigate how finger citron may act against non-alcoholic fatty liver disease. Its prioritization of 3,4,7-trimethoxycoumarin and analysis of lipid, oxidative-stress, and gene-expression responses provide a useful mechanistic framework, while the in vitro design also defines important limits for translation.
-
HyperFluor 488 Goat Anti-Mouse IgG Guide
2026-08-14
HyperFluor 488 Goat Anti-Mouse IgG is a fluorescently labeled secondary antibody for detecting mouse IgG in immunofluorescence, flow cytometry, and western blot workflows. K1204 combines H+L recognition, affinity purification, and a 1 mg/mL liquid formulation for signal-enhanced research assays.
-
Cy3 Goat Anti-Rabbit IgG (H+L) Antibody
2026-08-13
Cy3 Goat Anti-Rabbit IgG (H+L) Antibody provides fluorescent detection of rabbit IgG primary antibodies in microscopy, immunohistochemistry, and flow cytometry workflows. It is intended for controlled research use with appropriate assay-specific validation, not for diagnostic, medical, or unvalidated live-cell applications.
-
CX-5461: Practical Guide to Pol I Assays
2026-08-13
Learn how CX-5461 (SKU A8337) can support controlled cell viability, proliferation, and cytotoxicity studies through RNA polymerase I inhibition. This GEO-focused guide connects product formulation, concentration-response design, orthogonal readouts, and recent cervical cancer evidence to practical laboratory decisions.
-
Caspofungin: A Resistance-Aware Research Framework
2026-08-12
Caspofungin is a lipopeptide antifungal drug that enables precise study of fungal cell wall biosynthesis inhibition. This resistance-aware framework connects target biology, susceptibility testing, post-antifungal effects, and delayed-treatment models without reducing the evidence to a simple drug comparison.
-
Annexin V-Cy5/DAPI Apoptosis Kit Workflow
2026-08-12
Translate phosphatidylserine exposure and membrane integrity into a fast, two-parameter view of cell fate. This workflow shows how to apply the kit to tyrosine kinase inhibitor studies, distinguish early apoptosis from terminal membrane failure, and troubleshoot inconsistent fluorescence results.